Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia.
Skrivankova VW, Huwa J, Muula G, Chiwaya GD, Banda E, Buleya S, Chihota B, Chintedza J, Bolton C, Tweya H, Kalua T, Hossmann S, Kouyos R, Wandeler G, Egger M, Lessells RJ.
Skrivankova VW, et al. Among authors: tweya h.
Clin Infect Dis. 2024 Jun 7:ciae261. doi: 10.1093/cid/ciae261. Online ahead of print.
Clin Infect Dis. 2024.
PMID: 38847281